欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3896/001
药品名称Metronidazole Noridem 5 mg/ml, solution for infusion
活性成分
    • Metronidazole 5.0 mg/ml
剂型Solution for infusion
上市许可持有人Noridem Enterprises Ltd, Evagorou and Makariou 1, Mitsi Building 3, Office 115, Nicosia, CY-1065, Cyprus
参考成员国 - 产品名称Netherlands (NL)
Metronidazol Noridem 5 mg/ml
互认成员国 - 产品名称
    • Ireland (IE)
    • Belgium (BE)
      Metronidazole Noridem 500 mg/100 ml solution pour perfusion
    • Luxembourg (LU)
      Metronidazole Noridem, 500 mg / 100 mL, Solution pour perfusion
    • Austria (AT)
      Metronidazol BRADEX 5 mg/ml Infusionslösung
    • France (FR)
    • Hungary (HU)
      METRONIDAZOL NORIDEM 5 mg/ml oldatos infúzió
    • Czechia (CZ)
      Metronidazole Noridem 500 mg/100 ml, infuzní roztok
    • Slovakia (SK)
      Metronidazole Noridem 5 mg/ml infúzny roztok
    • Slovenia (SI)
      Metronidazol Noridem Enterprises 5 mg/ml raztopina za infundiranje
    • Croatia (HR)
      Metronidazol Noridem 5 mg/ml otopina za infuziju
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Metronidazol Noridem
    • Romania (RO)
    • Denmark (DK)
许可日期2018/10/09
最近更新日期2024/11/20
药物ATC编码
    • J01XD01 metronidazole
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase